Innovative and Applied Emerging Technologies in Biospecimen Science (R33)
Archived · United States of America
Source: Grants.gov
Purpose. This Funding Opportunity Announcement (FOA) issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), solicits grant applications proposing exceptionally innovative, high risk, original and/or unconventional exploratory research projects focused on the inception and early stage development of highly innovative cancer-relevant technologies for biospecimen science.
- Status
- Closed
- Sector
- Education, Power Transmission, Government, Power Generation (CCGT)
- Location
- United States of America
- Updated
- 22 Jul 2026
- Source
- Grants.gov
ConstructChat
Ask ConstructChat about Innovative and Applied Emerging Technologies in Biospecimen Science (R33)
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
Sponsoring Agency |
Status
Original status | archived |
Taiyo status | Closed |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | Purpose. This Funding Opportunity Announcement (FOA) issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), solicits grant applications proposing exceptionally innovative, high risk, original and/or unconventional exploratory research projects focused on the inception and early stage development of highly innovative cancer-relevant technologies for biospecimen science. The overall goal is to develop and evaluate technologies capable of interrogating or maximizing the quality and utility of biospecimens for molecular analyses with minimal invasiveness or compromise to donor/patient health. This FOA will also support the development of tools, devices, instrumentation, and associated methods to assess sample quality, preserve/protect sample integrity, and establish verification criteria for quality assessment/quality control and handling under diverse conditions. Projects must clearly demonstrate potential to produce a major impact in the area of biospecimen science. This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program. Several IMAT FOAs of identical or closely related scientific scope using various funding mechanisms are available. To facilitate selection, a separate Notice in the NIH Guide for Grants and Contracts provides brief cross-comparison and links to all the IMAT FOAs. See NOT-CA-09-007. |
Budget |
Location
Country | United States of America (USA) |
Source
Source reliability | High |
Source | Grants.gov |
URL |
More Details
Record type | Project |
Sector | Education, Power Transmission, Government, Power Generation (CCGT) |
Article published date | 2023-06-01 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
